CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors
Sung Han Kim, Eun Young Park, Hyung-Ho Lee, Jinsoo Chung, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(1):25-33.   Published online 2022 February 24    DOI: https://doi.org/10.22465/kjuo.2022.20.1.25

Excel Download

De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors
The Korean Journal of Urological Oncology. 2022;20(1):25-33   Crossref logo
Link1 Link2 Link3

Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors
Annals of Oncology. 2019;30:i3   Crossref logo
Link1 Link2 Link3

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Frontiers in Oncology. 2021;11:   Crossref logo
Link1

Prognostic Significance of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Metastatic Colorectal Cancer
. 2021;   Crossref logo
Link1 Link2

Albumin lymphocyte index is a better predictor of overall survival than neutrophil lymphocyte ratio in bladder cancer patients treated by radical radiotherapy
European Urology Open Science. 2020;21:S233   Crossref logo
Link1 Link2

Neutrophil-lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors
Annals of Oncology. 2019;30:xi5   Crossref logo
Link1 Link2 Link3 Link4

Prognostic Performance of the Derived Neutrophil-to-Lymphocyte Ratio in Stage IV Melanoma Patients Treated with Immune Checkpoint Inhibitors
Dermato. 2022;2(2):14-20   Crossref logo
Link1

Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis
Clinical Genitourinary Cancer. 2018;16(3):e685-e693   Crossref logo
Link1 Link2

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients
Oral Oncology. 2022;126:105729   Crossref logo
Link1 Link2

Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
International Immunopharmacology. 2020;85:106677   Crossref logo
Link1 Link2